QMB
QMB Logo

QMB Signalling Programme

Major Sponsor
Life Technologies
Major Academic Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors

The meeting will have sessions focussing on Signalling Pathways in Cancer, GPCR Signalling, Signalling Pathways Regulating Metabolism, Signalling Pathways Regulating Gene Expression, Redox Species and Signalling, Signalling in Plants, Cardiovascular Signalling.

Sunday 28th August
8.30 - 9.45amDrug Discovery and Signalling Pathways

Peter Shepherd, University of Auckland: Developing drugs targeting PI 3-kinase pathway
Jeanette Wood, S*Bio, Singapore: TBC
Christina Buchanan, University of Auckland: Finding new targets for DMXAA(Short Talk)
9.45 - 10.15amMorning Tea
10.15 -12:15 pm Signalling in Cardiovascular Tissues (Joint with Heart Satellite)

Jorgen Jensen, Oslo University: Complex cross-talk between insulin and b-adrenoceptor stimulation regulates PKB phosphorylation in rat cardiomyocytes
Julie McMullen, Baker Heart Institute, Melbourne: Role of the IGF1-PI3K pathway in the heart/ Targeting genes in the athlete's heart to treat heart failure
Regis Lambert, University of Otago: AMPK: cardiac regulator during metabolic stress
12.15 - 1.15pmLunch
1.30 - 3.30 Redox Signalling (Joint with Plant Satellite)

Simon Gilroy, University of Wisconsin: Abiotic stress and development: links through Ca2+ and ROS-dependent signalling cassettes
Christine Winterbourn, University of Otago, Christchurch: Redox signalling: principles, promise and pitfalls
Barry Scott, Massey University, Palmerston North: Oxidative stress signalling in Epichloe festucae, a mutualistic fungal symbiont of grasses
Mark Hampton, University of Otago, Christchurch: Peroxiredoxins as redox sensors and signalling proteins
4.00-6.00pm GPCR From Signalling to Drug Discovery

Patrick M Sexton, Monash Institute of Pharmaceutical Sciences: Drug action and signal bias at the glucagon-like peptide-1 receptor
Michelle Glass, University of Auckland: Trafficking of cannabinoid receptors: implications for drug tolerance
Debbie Hay, University of Auckland: The quest for adrenomedullin receptor antagonists for cancer
Nigel Bunnett, Monash Institute of Pharmaceutical Sciences: TBC
6.30 - 8.30pm Mixer and poster session
 
Monday 29th August
8.30 - 10.30am Signalling in Metabolic Tissues (II)

Andrew Butler, Scripps Institute, Florida, USA: Dissecting MC3R signalling using Cre/Lox technology reveals a role for ventromedial hypothalamic MC3R in metabolic homeostasis
George Muscat, Queensland Institute for Molecular Bioscience, Brisbane: The nuclear receptor, RORalpha, regulates lipid and carbohydrate metabolism
Kathy Mountjoy, University of Auckland: Diverse roles for Melanocortin Receptor Accessory Proteins in metabolism
Greg Smith, University of Auckland: Signalling pathways in liver metabolism
10.30 - 11.00amMorning Tea
11.00-1.15pm Other Signalling Pathways

Andy Morris, University of Kentucky: Multifunctional Regulation of Lipid Metabolism and Signaling by Lipin 1
Aimin Xu, Hong Kong University: Cross-talk between insulin and adiponectin signaling: Molecular mechanisms and physiological implications
Evelyn Sattlegger, Massey University, Albany: Revealing novel links between protein synthesis and the nutrient sensor Gcn2
Emmanuelle Cognard, University of Auckland: Nutrient regulation of Wnt/beta-catenin signaling pathways (Short talk)
Ye Guan Chen, Tsing Hua University, Beijing: Wnt signalling and autophagy
1.15-2.15pmLunch
2.15-4.15pm Signalling Pathways and Cancer

Jeong Park, Massey University, Palmerston North: TRRAP to SANTA: Roles of TRRAP-p400 complex from transcription to signal transduction pathway
Mark Gutheridge, University of Melbourne: Cytokine signalling in leukemia
David Fruman, University of California, Irvine: PI 3-kinase pathway and leukemia
Wayne Phillips, Peter MacCallum Cancer Centre, Melbourne: PI 3-kinase signalling in cancer

Satellite meeting closes.

Those staying on are welcome to attend plenary lecture at opening of QMB meeting by Prof Barry Marshall who won the Nobel Prize for Medicine in 2005 and afterwards the Illumina party that follows (venue to be announced later).